Back
Mersana Therapeutics Vs. Marinus Pharmaceuticals Industry Stock Comparison
Sell
46
MRSN
Mersana Therapeutics
Last Price:
2.13
Seasonality Move:
41.89%
Sell
49
MRNS
Marinus Pharmaceuticals
Last Price:
1.78
Seasonality Move:
4.53%
Sell
46
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy, Sell or Hold?
- The current Mersana Therapeutics [MRSN] share price is $2.12. The Score for MRSN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- MRSN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.79. The Score for MRNS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRSN Stock Price Chart
What is Mersana Therapeutics's stock price today?
-
The Mersana Therapeutics share price today is $2.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRSN is experiencing slight buying pressure.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing slight buying pressure.
MRSN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 61.73 | Buy |
| Chaikin Money Flow: | 769876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.58 - 2.08) | Buy |
| Bollinger Bands (100): | (1.59 - 2.31) | Buy |
MRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 61.8 | Buy |
| Chaikin Money Flow: | 153915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.42 - 1.74) | Buy |
| Bollinger Bands (100): | (1.25 - 1.57) | Buy |
MRSN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.93 | Buy |
| 20-day SMA: | 1.92 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 2.81 | Sell |
| 8-day EMA: | 1.98 | Buy |
| 20-day EMA: | 1.89 | Buy |
| 50-day EMA: | 1.85 | Buy |
| 200-day EMA: | 2.47 | Sell |
MRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.75 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 1.44 | Buy |
| 200-day SMA: | 4.65 | Sell |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.65 | Buy |
| 50-day EMA: | 1.58 | Buy |
| 200-day EMA: | 3.56 | Sell |
Mersana Therapeutics Earnings Growth & MRSN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.00 per share.
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.96 per share.
Mersana Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Marinus Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||